Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055

Journal of Medical Microbiology

Volumn 60, Issue 2, 2011, Pages 205-210

  Kumari, Seema ^a   Harjai, Kusum ^a   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PARACETAMOL; SILVER NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIOPHAGE KPN5; BURN INFECTION; CELL STRAIN B5055; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HYDROGEL; KLEBSIELLA PNEUMONIAE; MORTALITY; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SURVIVAL; VIROTHERAPY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIOPHAGES; BURNS; COMPLEMENTARY THERAPIES; DISEASE MODELS, ANIMAL; GENTAMICINS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; MICE, INBRED BALB C; SILVER NITRATE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WOUND INFECTION;

EID: 79251485319     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.018580-0     Document Type: Article

References (45)

1. Adams, M. H. (1959). Bacteriophages, pp. 450-456. New York: Interscience Publishers.
2. Atkinson, B. A. (1980). Species incidence, trends of susceptibility to antibiotics in the United States and minimum inhibitory concentration. In Antibiotics in Laboratory Medicine, pp. 607-722. Edited by V. Lorian. Baltimore: Williams & Wilkins.
3. Basketter, D. A., York, M., McFadden, J. P. & Robinson, M. K. (2004). Determination of skin irritation potential in the human 4-h patch test. Contact Dermatitis 51, 1-4.
4. Bedi, M. S., Verma, V. & Chhibber, S. (2009). Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol 25, 1145-1151.
5. Bradbury, J. (2004). "My enemy's enemy is my friend." Using phages to fight bacteria. Lancet 363, 624-625.
6. Chhibber, S., Kaur, S. & Kumari, S. (2008). Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 57, 1508-1513.
7. Chopra, I. (2007). The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 59, 587-590.
8. Church, D., Elsayed, S., Reid, O., Winston, B. & Lindsay, R. (2006). Burn wound infections. Clin Microbiol Rev 19, 403-434.
9. Cook, N. (1998). Methicillin resistant Staphylococcus aureus versus the burned patient. Burns 24, 91-98.
10. Cooper, J. W. (1989). Cooper and Gunn's Dispensing for Pharmaceutical Students, 12th edn. Edited by S. J. Carter. Edinburgh: Churchill Livingstone.
11. Dale, R. M. K., Schnell, G. & Wong, J. P. (2004). Therapeutic efficacy of "Nubiotics" against burn wound infection by Pseudomonas aeruginosa. Antimicrob Agents Chemother 48, 2918-2923.
12. Dunn, K. & Edwards-Jones, V. (2004). The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns 30, S1-S9.
13. Erol, S., Altoparlak, U., Akcay, M. N., Celebi, F. & Parlak, M. (2004). Changes of microbial flora and wound colonization in burned patients. Burns 30, 357-361.
14. Fox, C. L., Jr (1968). Silver sulphadiazin: a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 96, 184.
15. Górski, A., Targońska, M., Borysowski, J. & Weber-Da̧browska, B. (2009). The potential of phage therapy in bacterial infections of the eye. Ophthalmologica 223, 162-165.
16. Hanlon, G. W. (2007). Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30, 118-128.
17. Heggers, J. P., Sazy, J. A., Stenberg, B. D., Strock, L. L., McCauley, R. L., Herndon, D. N. & Robson, M. C. (1991). Bactericidal and wound-healing properties of sodium hypochlorite solutions: the 1991 Lindberg Award. J Burn Care Rehabil 12, 420-424.
18. Inal, J. M. (2003). Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immunol Ther Exp (Warsz) 51, 237-244.
19. Ip, M., Lui, S. L., Poon, V. K. M., Lung, I. & Burd, A. (2006). Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55, 59-63.
20. Kapoor, N., Chhibber, S. & Vadehra, D. V. (1989). Susceptibility of multidrug-resistant isolates of Klebsiella pneumoniae to silver nitrate. Folia Microbiol (Praha) 34, 94-98.
21. Kumari, S., Harjai, K. & Chhibber, S. (2009). Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J Microbiol Biotechnol 19, 622-628.
22. Lansdown, A. B. (2005). A guide to the properties and uses of silver dressings in wound care. Prof Nurse 20, 41-43.
23. Malik, R. & Chhibber, S. (2009). Protection with bacteriophages KØ1 against lethal K. pneumoniae induced burn wound infection in mice. J Microbiol Immunol Infect 42, 134-140.
24. Manafi, A., Hashemlou, A., Momeni, P. & Moghimi, H. R. (2008). Enhancing drugs absorption through third-degree burn wound eschar. Burns 34, 698-702.
25. Matsuzaki, S., Rashel, M., Uchiyma, J., Ujihara, T., Kuroda, M., Ikeuchi, M., Fujieda, M., Wakiguchi, J. & Imai, S. (2005). Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 11, 211-219.
26. Mayhall, C. G. (2003). The epidemiology of burn wound infections: then and now. Clin Infect Dis 37, 543-550.
27. McVay, C. S., Velásquez, M. & Fralick, J. A. (2007). Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51, 1934-1938.
28. Moyer, C. A., Brentano, L., Gravens, D. L., Margraf, N. W. & Manafo, W. W. (1965). Treatment of large human burns with 5% silver nitrate solution. Arch Surg 90, 812-867.
29. Noronha, C. & Almeida, A. (2000). Local burn treatment - topical antimicrobial agents. In Annals of Burns and Fire Disasters, vol. XIII, no. 4. Palermo: Mediterranean Council for Burns and Fire Disasters.
30. Ollstein, R. N. & McDonald, C. (1980). Topical and systemic antimicrobial agents in burns. Ann Plast Surg 5, 386-392.
31. O'Neill, M. A., Vine, G. J., Beezer, A. E., Bishop, A. H., Hadgraft, J., Labetoulle, C., Walker, M. & Bowler, P. G. (2003). Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. Int J Pharm 263, 61-68.
32. Ozumba, U. C. & Jiburum, B. C. (2000). Bacteriology of burn wounds in Enugu, Nigeria. Burns 26, 178-180.
33. Panjeshahin, M. R., Lari, A. R., Talei, A., Shamsnia, J. & Alaghehbandan, R. (2001). Epidemiology and mortality of burns in the South West of Iran. Burns 27, 219-226.
34. Pruitt, B. A., McManus, A. T., Kim, S. H. & Goodwin, C. W. (1998). Burn wound infections: current status. World J Surg 22, 135-145.
35. Shukla, I., Tiwari, R. & Agrawal, M. (2004). Prevalence of extended spectrum b-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol 22, 87-91.
36. Skurnik, M., Pajunen, M. & Kiljunen, S. (2007). Biotechnological challenges of phage therapy. Biotechnol Lett 29, 995-1003.
37. Snelling, C. F. T., Ronal, A. R., Waters, W. R., Yaworski, D. S., Drulak, K. & Sunderland, M. (1978). Comparison of silver sulphadiazine and gentamicin for topical prophylaxis against burn wound sepsis. Can Med Assoc J 119, 466-470.
38. Steen, M. (1993). Review of the use of povidone-iodine (PVP-I) in the treatment of burns. Postgrad Med J 69, S84-S92.
39. Taneja, N., Emmanuel, R., Chari, P. S. & Sharma, M. (2004). A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India. Burns 30, 665-669.
40. Ulkür, E., Oncül, O., Karagöz, H., Celiköz, B. & Cavuşlu, S. (2005). Comparison of silver-coated dressing (Acticoat™), chlorhexidine acetate 0.5% (Bactigrass®), and silver sulfadiazine 1% (Silverdin®) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. J Burn Care Rehabil 26, 430-433.
41. Verma, V., Harjai, K. & Chhibber, S. (2009). Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother 64, 1212-1218.
42. Vinodkumar, C. S., Kalsurmath, S. & Neelagund, Y. F. (2008). Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Indian J Pathol Microbiol 51, 360-366.
43. Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L. & other authors (2006). Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int J Mol Med 17, 309-317.
44. Ward, R. S. & Saffle, J. R. (1995). Topical agents in burn and wound care. Phys Ther 75, 526-538.
45. Wills, Q. F., Kerrigan, C. & Soothill, J. S. (2005). Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob Agents Chemother 49, 1220-1221.